Pharmacovigilance Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32 - PowerPoint PPT Presentation

About This Presentation
Title:

Pharmacovigilance Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

Description:

According to the latest research report by IMARC Group, The global pharmacovigilance market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 7 August 2024
Slides: 18
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Pharmacovigilance Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32


1
Global Pharmacovigilance Market Research and
Forecast Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Pharmacovigilance Market Global Industry
    Trends, Share, Size, Growth, Opportunity and
    Forecast 2024-2032," the global pharmacovigilance
    market size reached US 7.9 Billion in 2023.
  • Pharmacovigilance (PV) is the pharmacological
    science of studying the detection, assessment,
    and prevention of unfavorable effects of
    pharmaceutical medicines. It plays a critical
    role in identifying previously unknown ADR
    (adverse drug reactions) and drug toxicity,
    determining changes in frequency or severity, and
    assessing the risks and benefits of drugs to
    determine required actions.
  • It also assures the accuracy of communicated
    information to healthcare professionals and
    patients. As a result, PV is widely used to
    comprehend the effects of drugs on individuals
    across the globe.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/pharmacovigilance-marke
    t/requestsample

4
Report Description
  • Global Pharmacovigilance Market Trends
  • The market is primarily driven by the rising
    prevalence of chronic diseases, such as diabetes,
    hypertension, oncological diseases, and cardiac
    disorders, resulting in the increasing
    consumption of drugs worldwide. In addition, the
    introduction of advanced platforms to ensure
    automated ADR reporting is contributing to market
    growth. Moreover, the sudden outbreak of
    coronavirus disease (COVID-19) and the consequent
    necessity for vaccination has also created
    several opportunities for the market players.
    This, coupled with the widespread adoption of new
    technologies in clinical research, such as the
    incorporation of virtual services in the clinical
    trial protocol, is augmenting the market growth.
  • Besides this, leading companies are undertaking
    various initiatives to conduct clinical trials
    and generate awareness about the proper
    utilization of medicines, which is facilitating
    the market growth. Along with this, extensive
    research and development (RD) activities
    conducted by major pharmaceutical and
    biotechnological companies to develop new drugs
    are providing a positive thrust to the market
    growth.
  • Looking forward, IMARC Group expects the market
    value to reach US 15.9 Billion by 2032,
    exhibiting a CAGR of 7.8 during the forecast
    period (2024-2032).
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/pharmacovigilance-marke
    t

5
Report Segmentation
  • Breakup by Service Provider
  • In-house
  • Contract Outsourcing
  •  
  • Breakup by Product Life Cycle
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Breakup by Type
  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring

6
Report Segmentation
  • EHR Mining
  • Breakup by Process Flow
  • Case Data Management
  • Case Logging
  • Case Data Analysis
  • Medical Reviewing and Reporting
  • Signal Detection
  • Adverse Event Logging
  • Adverse Event Analysis
  • Adverse Event Review and Reporting
  • Risk Management System
  • Risk Evaluation System

7
Report Segmentation
  • Risk Mitigation System
  • Breakup by Therapeutic Area
  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others
  • Breakup by End Use
  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Others

8
Report Segmentation
  • Breakup by Region
  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

9
Competitive Landscape with Key Players
  • Accenture plc
  • ArisGlobal LLC
  • BioClinica Inc. (Cinven Partners LLP)
  • Capgemini
  • Cognizant
  • International Business Machines Corporation
  • ICON plc.
  • IQVIA Inc.
  • ITClinical
  • Parexel International Corporation
  • Wipro Limited

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Pharmacovigilance
    Market    5.1    Market Overview    5.2  
     Market Performance    5.3    Impact of
    COVID-19  5.4    Market Forecast
  • 6     Market Breakup by Service Provider
  • 6.1 In-house
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
  • 6.2 Contract Outsourcing
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
  • 7 Market Breakup by Product Life Cycle
  • 7.1 Pre-clinical
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast       

13
Table of Contents
  • 7.2 Phase I
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
  • 7.3 Phase II
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
  • 7.4 Phase III
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
  • 7.5 Phase IV
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
  • 8 Market Breakup by Type
  • 8.1 Spontaneous Reporting
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
  • 8.2 Intensified ADR Reporting
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

14
Partial List of Clients
15
Partial List of Clients
16
Disclaimer
  • 2024 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

17
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us
Write a Comment
User Comments (0)
About PowerShow.com